Explore STIWatch.org and get the latest resources to navigate the IUSTI & STI Prevention meetings!
STIWatch.org is an updated platform designed to enhance understanding and advocacy for STI vaccine and diagnostics research, development, and rollout.
P-Values
Discover perspectives on the latest findings, biggest challenges and most exciting successes in our collective work.
At P-Values, you’ll find updates, perspective, insights and information from staff and partners working on the frontlines of research, advocacy and implementation. P-value is a statistical term for the probability that a trial result is reliable and not the outcome of chance.
Featured
HIV self-testing and PrEP, fighting health misinformation, innovations in GPP, and more!
This week AVAC is hosting a webinar on Innovations in GPP, sharing two new briefs to support PrEP access, a new podcast on strategies to counter health misinformation, and much more!
Innovations in GPP, wins for U=U, expanding PrEP access and more!
A brand-new webinar highlighting the innovations of GPP, a roundup of recordings and materials from our August webinars and the latest PxPulse Advocacy Chronicles discussing a U=U win in South Africa in our roundup.
P-Values
showing 1-10 of 1028
Explore STIWatch.org and get the latest resources to navigate the IUSTI & STI Prevention meetings!
STIWatch.org is an updated platform designed to enhance understanding and advocacy for STI vaccine and diagnostics research, development, and rollout.
Prevention Option:
HIV self-testing and PrEP, fighting health misinformation, innovations in GPP, and more!
This week AVAC is hosting a webinar on Innovations in GPP, sharing two new briefs to support PrEP access, a new podcast on strategies to counter health misinformation, and much more!
Innovations in GPP, wins for U=U, expanding PrEP access and more!
A brand-new webinar highlighting the innovations of GPP, a roundup of recordings and materials from our August webinars and the latest PxPulse Advocacy Chronicles discussing a U=U win in South Africa in our roundup.
HIV leaders say it’s time to end the long wait for long acting products
How do we translate recent scientific advances in long-acting HIV prevention and therapy into public health impact? Read answers in this new The Lancet HIV commentary from a distinguished group of authors including our Executive Director, Mitchell Warren, AVAC board members, Linda-Gail Bekker, Solange Baptiste Simon, with partners Francois Venter, Kenly Sikwese, and others: The long wait for long-acting HIV prevention and treatment formulations.
Prevention Option:
New Peer-Reviewed Articles, Upcoming Webinars & More!
AVAC and partners authored three new peer-reviewed articles this month on a range of HIV prevention issues. From the potential and challenges of long-acting formulations in HIV care, to the benefits of delivering family planning AND PrEP using pharmacies, e-pharmacies and private sector clinics, to the necessity for gender-transformative approaches to ensure effective and equitable participation of women in biomedical prevention trials, these are must-read pieces.
Prevention Option:
What’s Next for the Dual Prevention Pill (DPP)
The latest edition of the Journal of the International AIDS Society features newly published research by AVAC and partners on the benefits of delivering family planning and PrEP using pharmacies, e-pharmacies and telemedicine, in addition to private sector clinics.
Prevention Option:
Navigating the PrEP Landscape
With a growing number of PrEP products in development and approved for use in various countries, and an increase in PrEP initiations worldwide, the future of PrEP has never been more exciting. Check out our newly redesigned PrEPWatch website to help navigate the latest research, policy developments, implementation strategies, and advocacy efforts worldwide. The updated site features an array of expanded PrEP resources and improved navigation. We hope PrEPWatch and its resources will be helpful in your advocacy.
Prevention Option:
Choice, Access and Equity at AIDS 2024
Choice, access, and equity were central themes during the sessions and discussions at #AIDS2024 on Wednesday and Thursday. Highlights included new data on long-acting cabotegravir, a plenary calling out the need to move with speed, scale and equity in the rollout of new PrEP options, updated guidelines to improve access to post-exposure prophylaxis (PEP), a renewed commitment to the African Women’s Choice Manifesto, new data highlighting the omission of key populations from sustainability planning, and much more.
LEN in the Spotlight at AIDS 2024
Midpoint at #AIDS2024 in Munich, one of the most significant advances in HIV prevention in the history of the response, the efficacy of lenacapavir as PrEP, was presented at the Co-Chair’s Choice session. The findings, zero infections and 100% efficacy among the trial participants in the PURPOSE 1 trial, brought a standing ovation.
First Full Day of AIDS 2024
Lenacapavir for PrEP has taken center stage at the 25th International AIDS Conference, #AIDS2024, which opened Monday with many highlighting its potential for long-acting PrEP for HIV prevention. “It is gobsmackingly exciting to see zero in a clinical trial” AVAC’s Mitchell Warren told Forbes. The potential to bend the curve of the epidemic depends on speeding access to prevention options like LEN, that show high efficacy.
Prevention Option:
showing 1-10 of 1028
Explore More News and Communications
P-Values Blog
Discover perspectives on the latest findings, biggest challenges and most exciting successes in our collective work.
Advocates Network
AVAC’s email list for organization and individuals interested in timely updates and critical perspectives on developments in biomedical HIV prevention.
Weekly News Digest
A comprehensive round-up of HIV prevention media coverage and scientific publications.
PxPulse
Each month this podcast uses interviews, discussion and first-person reflections to explore vital topics confronting the field of HIV prevention research.
PxWire
PxWire is AVAC’s quarterly update on biomedical HIV prevention. Each issue highlights key developments, challenges and opportunities, and features a centerspread infographic that provides a visual tool for framing these issues.
Pandemic Watch
Pandemic Watch is a curated news digest on the latest pandemic prevention, preparedness, and response (PPPR) news and resources.
Press Releases
A collection of official statements from AVAC.
AVAC in the News
Media clippings featuring AVAC, its staff and close partners in the news media.